Skip to content

General Catalyst Group Management, LLC

Follow

13F filer, CIK 1637946, Cambridge, MA

General Catalyst Group Management, LLC reported $478,243,250 across 13 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 99.82% of the portfolio.

Accepted , ingested 13F-HR 0000905148-26-004909

Period
2026-09-30
Reported value
$478M
Holdings
13
Top 10 weight
99.82%
New
3
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
QCOMnew+1,583,487$291M
OSCRnew+299,923$9.25M
CPNGadded+24,500$340K
CVNAadded+2,300$144K
MLMnew+175$84K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
EIKNexited-305,233-$3.98M
GUTSexited-4,884,186-$3.88M
LIFEexited-74,179-$1.35M
DASHreduced-1,550-$285K
FIGexited-14,845-$269K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0000905148-26-004909, largest first. % of portfolio is the value over $478,243,250, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
QCOMQUALCOMM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,583,487 shares 1,583,487$291M60.94%newTimeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,600,937 shares; 2026Q3: 1,600,937 shares 1,600,937$51.7M10.81%0Timeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,494,786 shares; 2025Q1: 1,494,786 shares; 2025Q2: 1,494,786 shares; 2025Q3: 1,494,786 shares; 2025Q4: 1,494,786 shares; 2026Q1: 1,494,786 shares; 2026Q2: 1,494,786 shares; 2026Q3: 1,494,786 shares 1,494,786$45.3M9.46%0Timeline
CARTMAPLEBEAR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 710,711 shares; 2025Q1: 710,711 shares; 2025Q2: 710,711 shares; 2025Q3: 710,711 shares; 2025Q4: 710,711 shares; 2026Q1: 710,711 shares; 2026Q2: 710,711 shares; 2026Q3: 710,711 shares 710,711$30.6M6.41%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,035,910 shares; 2025Q2: 1,035,910 shares; 2025Q3: 1,035,910 shares; 2025Q4: 1,035,910 shares; 2026Q1: 1,035,910 shares; 2026Q2: 1,035,910 shares; 2026Q3: 1,035,910 shares 1,035,910$28.2M5.89%0Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 810,272 shares; 2026Q3: 810,272 shares 810,272$18M3.76%0Timeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,107,719 shares; 2025Q1: 2,107,719 shares; 2025Q2: 2,107,719 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 299,923 shares 299,923$9.25M1.93%newTimeline
CPNGCOUPANG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 36,677 shares; 2026Q2: 54,677 shares; 2026Q3: 79,177 shares 79,177$1.1M0.23%+24,500Timeline
METAMETA PLATFORMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 658 shares; 2026Q2: 1,320 shares; 2026Q3: 1,320 shares 1,320$957K0.2%0Timeline
AMZNAMAZON COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,582 shares; 2026Q2: 3,882 shares; 2026Q3: 3,532 shares 3,532$880K0.18%-350Timeline
CVNACARVANA COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,465 shares; 2026Q3: 8,765 shares 8,765$548K0.11%+2,300Timeline
DASHDOORDASH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,850 shares; 2026Q3: 1,300 shares 1,300$239K0.05%-1,550Timeline
MLMMARTIN MARIETTA MATLS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 175 shares 175$84K0.02%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
EIKNEIKON THERAPEUTICS INC305,233$3.98Mshares
GUTSFRACTYL HEALTH INC4,884,186$3.88Mshares
LIFEETHOS TECHNOLOGIES INC74,179$1.35Mshares
FIGFIGMA INC14,845$269Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000905148-26-004909 base2026-11-16